about
Considerations for using genetic and epigenetic information in occupational health risk assessment and standard settingCombined toxic exposures and human health: biomarkers of exposure and effectReview of pesticide urinary biomarker measurements from selected US EPA children's observational exposure studiesAn Overview of Literature Topics Related to Current Concepts, Methods, Tools, and Applications for Cumulative Risk Assessment (2007-2016)Human biomonitoring data interpretation and ethics; obstacles or surmountable challenges?Integrated exposure assessment of sewage workers to genotoxicants: an urinary biomarker approach and oxidative stress evaluationNon-chemical stressors and cumulative risk assessment: an overview of current initiatives and potential air pollutant interactions.Vulnerability as a function of individual and group resources in cumulative risk assessmentIf cumulative risk assessment is the answer, what is the question?A phased approach for assessing combined effects from multiple stressorsCumulative risk assessment: an overview of methodological approaches for evaluating combined health effects from exposure to multiple environmental stressors.A decade of environmental public health tracking (2002-2012): progress and challenges.Developmental neurotoxicity of the organophosphorus insecticide chlorpyrifos: from clinical findings to preclinical models and potential mechanisms.Preparation and performance features of wristband samplers and considerations for chemical exposure assessment.Modeling autism: a systems biology approach.Mercury concentrations in hair from neonatal and juvenile Steller Sea Lions (Eumetopias jubatus): implications based on age and region in this northern Pacific marine sentinel piscivore.Pathogenic infection confounds induction of the estrogenic biomarker vitellogenin in rainbow trout.
P2860
Q23919015-C9A844F0-6C53-4A90-88A9-02D627F20C3BQ28388151-15DBCA09-699F-4367-9AAF-FAFEA3C192B7Q28389065-D63AD993-80A4-4137-99D0-A9B38C50220DQ30234908-5939D0F2-9F9E-493C-9813-07C4062E8CC9Q31158564-12A9BB05-936B-4489-BA0A-C2C4AD890799Q34764727-3DF72B21-2E31-4A99-8E5C-AF16441E0DCCQ35110097-0D7E2918-50D4-4860-A1EB-70E481B415F1Q35790994-99F6333A-14A9-4D9B-A943-81430630408CQ35791033-9830149A-23C0-4BD1-B14E-1F6BEB007A31Q35791066-7D414349-2B89-4E50-ABCD-DFFD5EDAA312Q35860423-3CFAFB91-0F04-41AD-98A8-AEC93B9A448FQ38332613-9AE7B502-0309-451B-80C0-938D241D93F1Q40089667-B3348728-A229-476F-8CD4-EFCD38F253CEQ40107989-58F57917-C77E-40F2-9361-260185F91DD9Q42062971-3C993B6E-18CF-4F8B-A1B8-816F90F9CA6CQ43475186-AA05DE3E-7C0B-4C3B-A2D9-B8B26D3D53CDQ44324662-8F9C4D2C-27E6-4040-993B-5F615B3EB4B7
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Using biomarkers to inform cumulative risk assessment
@ast
Using biomarkers to inform cumulative risk assessment
@en
Using biomarkers to inform cumulative risk assessment
@nl
type
label
Using biomarkers to inform cumulative risk assessment
@ast
Using biomarkers to inform cumulative risk assessment
@en
Using biomarkers to inform cumulative risk assessment
@nl
prefLabel
Using biomarkers to inform cumulative risk assessment
@ast
Using biomarkers to inform cumulative risk assessment
@en
Using biomarkers to inform cumulative risk assessment
@nl
P2093
P2860
P356
P1476
Using biomarkers to inform cumulative risk assessment
@en
P2093
Elaine A Cohen Hubal
Jerome J Cura
P Barry Ryan
Thomas A Burke
Thomas E McKone
P2860
P304
P356
10.1289/EHP.9334
P407
P577
2007-05-01T00:00:00Z